Matthias Endres - Biography#
Matthias Endres (1969) completed his medical studies at the University of Hamburg in 1994 and received his doctorate in 1995 in the Department of Microbiology and Medical Immunology under Prof. Rainer Laufs. He began his specialist training in neurology at the Medical University of Lübeck, Germany, where he also became interested in stroke research. From 1996 to 1998, Matthias Endres was a post-doctoral fellow at the Stroke and Neurovascular Regulation Laboratory of Prof. Michael A. Moskowitz at Massachussetts General Hospital, Harvard Medical School in Boston/Charlestown, USA. His research interests focused on animal models of stroke and he made seminal discoveries about the role of apoptosis in cerebral ischemia, in particular by establishing a mouse model of mild ischemic stroke with delayed neuronal cell death. Another important work was his publication on the stroke-protective effect of statins through the upregulation of endothelial nitric oxide synthase.
In 1998, Matthias Endres continued his clinical training at the Department of Neurology at the Charité in Berlin under Prof. Karl Einhäupl. At the same time, he was a group leader in interdisciplinary stroke research in the Department of Experimental Neurology under Prof. Ulrich Dirnagl. His work includes mechanisms of cell death, regeneration and repair as well as neurovascular regulation. In particular, Matthias Endres characterized the long-term behaviour including neuropsychiatric mechanisms in mouse models of stroke. Matthias Endres habilitated in 2001 and passed his state examination in neurology in 2002. In 2003 he became a Heisenberg Fellow of the German Research Foundation, and in 2005 he was awarded a Lichtenberg Professorship at the Charité.
In 2008, he was appointed Founding Director of the Center for Stroke Research Berlin and W3 Professor and Chair of the Department of Neurology at Charité. In 2009, he also took over the position of Medical Director of the Charité Center for Neurology, Neurosurgery and Psychiatry.
Matthias Endres was spokesperson of the Clinical Research Unit on Deep Brain Stimulation funded by the German Research Foundation from 2010-2019 and is now spokesperson of the newly funded Clinical Research Unit BeCAUSE-Y on Neuronal Autoimmunity. Matthias Endres is a principal investigator in the DFG NeuroCure Cluster of Excellence and in the German Research Centers for Neurodegenerative Diseases (DZNE), Cardiovascular Research (DZHK) and Mental Health (DZPG).
As the author of more than 550 publications in peer-reviewed journals with a cumulative impact factor of >4200, Matthias Endres has an h-index of 115 according to Goocle scholar. Matthias Endres has received numerous national and international awards, was a visiting professor at the University of Oxford, UK and is a member of the German Academy of Sciences Leopoldina.
